Afuresertib is an inhibitor of Akt, a serine/threonine kinase. In addition to showing efficacy in clinical trials as a monotherapy against hematological malignancies, afuresertib has been effective against multiple myeloma. When used in combination with pomalidomide plus dexamethasone, afuresertib exhibited antitumor activity in multiple myeloma cells. It has also shown efficacy in patients with malignant pleural mesothelioma.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































